Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
In alternative embodiments, the invention provides compositions, e.g., formulations, used for gastric, gastrointestinal and/or colonic treatments or lavage, e.g., orthostatic lavage, e.g., for inducing the purgation (e.g., cleansing) of a gastrointestinal (GI) tract, including a colon; and methods for making and using them. In alternative embodiments, compositions and methods of the invention are used for the stabilization, amelioration, treatment and/or prevention of constipation, for the treatment of abdominal pain, particularly non-specific abdominal pain, and diarrhea, including diarrhea caused by a drug side effect, a psychological condition, a disease or a condition such as Crohn's Disease, a poison, a toxin or an infection, e.g., a toxin-mediated traveler's diarrhea, or C. difficile or the pseudo-membranous colitis associated with this infection. In alternative embodiments, the invention provides pharmaceuticals and products (articles) of manufacture for delivering these compositions and formulations to an individual, e.g., a human or an animal. The invention also provides devices for delivering a fecal material to a patient.
1. A method comprising:
receiving at a central location a stool sample from a healthy donor;
placing the stool sample within a stool collection device;
mixing the stool sample with a liquid to form a mixture, wherein the liquid comprises a buffer;
homogenizing and filtering the mixture to separate fiber from bacteria and produce a filtrate comprising a substantially entire microbiota of the stool sample; and
selectively removing bacteria from the filtrate to produce a composition comprising bacterial species of the phylum Firmicutes.
2. The method of claim 1 , wherein the selectively removed bacteria comprise Bacteroides.
3. The method of claim 1 , wherein the composition comprises a bacterial population consisting essentially of bacterial species of the phylum Firmicutes.
4. The method of claim 3 , wherein the selectively removed bacteria comprise Bacteroides.
5. The method of claim 1 , wherein the liquid comprises a cryoprotectant.
6. The method of claim 5 , wherein the cryoprotectant comprises trehalose.
7. The method of claim 1 , wherein the filtrate further comprises an antioxidant.
8. The method of claim 1 , wherein the method further comprises freezing or lyophilizing the composition.
9. The method of claim 8 , wherein the method further comprises encapsulating the frozen or lyophilized composition into a carrier.
10. The method of claim 1 , wherein the mixture, the filtrate, the composition, or any combination thereof is maintained in an at least 95% oxygen free environment.
11. The method of claim 1 , wherein the method further comprises adding one or more cultured bacteria to the filtrate.
12. The method of claim 1 , wherein the method comprises recurrent filtration with decreasing filter sizes.
13. A method comprising:
receiving at a central location a stool sample from a healthy donor, wherein the donor has been prescreened for infectious agents;
placing the stool sample within a stool collection device;
mixing the stool sample with a liquid to form a mixture, wherein the liquid comprises a buffer;
homogenizing and filtering the mixture to produce a filtrate comprising a substantially entire microbiota of the stool sample, wherein the filtrate is free of rough particulate matter of the stool sample; and
selectively removing bacteria from the filtrate to produce a composition comprising bacterial species of the phylum Firmicutes.
14. The method of claim 13 , wherein the selectively removed bacteria comprise Bacteroides.
15. The method of claim 13 , wherein the composition comprises a bacterial population consisting essentially of bacterial species of the phylum Firmicutes.
16. The method of claim 15 , wherein the selectively removed bacteria comprise Bacteroides.
17. The method of claim 13 , wherein the liquid or the filtrate comprises a cryoprotectant, an antioxidant, or both.
18. The method of claim 17 , wherein the cryoprotectant comprises trehalose.
19. The method of claim 13 , wherein the method further comprises adding one or more cultured bacteria to the filtrate.
20. The method of claim 13 , wherein the method comprises recurrent filtration with decreasing filter sizes.